ClariVest Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.36K | Hold |
1,317
| – | – | ﹤0.01% | 424 |
|
|
2024
Q2 | $8.36K | Buy |
1,317
+449
| +52% | +$2.85K | ﹤0.01% | 424 |
|
|
2024
Q1 | $5.26K | Buy |
868
+135
| +18% | +$818 | ﹤0.01% | 455 |
|
|
2023
Q4 | $4.45K | Buy |
733
+160
| +28% | +$971 | ﹤0.01% | 465 |
|
|
2023
Q3 | $3K | Buy |
573
+187
| +48% | +$979 | ﹤0.01% | 463 |
|
|
2023
Q2 | $1K | Hold |
386
| – | – | ﹤0.01% | 576 |
|
|
2023
Q1 | $1K | Sell |
386
-97,424
| -100% | -$252K | ﹤0.01% | 609 |
|
|
2022
Q4 | $195K | Sell |
97,810
-160
| -0.2% | -$319 | 0.01% | 420 |
|
|
2022
Q3 | $198K | Sell |
97,970
-266
| -0.3% | -$538 | 0.01% | 421 |
|
|
2022
Q2 | $312K | Sell |
98,236
-49,282
| -33% | -$157K | 0.01% | 428 |
|
|
2022
Q1 | $616K | Buy |
147,518
+34,079
| +30% | +$142K | 0.02% | 349 |
|
|
2021
Q4 | $543K | Sell |
113,439
-3,816
| -3% | -$18.3K | 0.02% | 422 |
|
|
2021
Q3 | $626K | Sell |
117,255
-2,927
| -2% | -$15.6K | 0.02% | 404 |
|
|
2021
Q2 | $614K | Buy |
120,182
+162
| +0.1% | +$828 | 0.02% | 397 |
|
|
2021
Q1 | $808K | Buy |
120,020
+118,862
| +10,264% | +$800K | 0.03% | 318 |
|
|
2020
Q4 | $5K | Hold |
1,158
| – | – | ﹤0.01% | 582 |
|
|
2020
Q3 | $4K | Hold |
1,158
| – | – | ﹤0.01% | 565 |
|
|
2020
Q2 | $6K | Buy |
+1,158
| New | +$6K | ﹤0.01% | 606 |
|